Table 1.
Participant baseline characteristics
| V181 TV003 Formulation |
V181 TV005 Formulation |
Placebo |
||||
|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | |
| Participants in population | 80 | 80 | 40 | |||
| Male | 30 | (37.5) | 28 | (35.0) | 17 | (42.5) |
| Female | 50 | (62.5) | 52 | (65.0) | 23 | (57.5) |
| Mean Age, Years (Range) | 35.0 (19 to 49) | 34.9 (18 to 50) | 34.7 (19-51†) | |||
| Race | ||||||
| American Indian or Alaska Native | 2 | (2.5) | 2 | (2.5) | 0 | (.0) |
| Asian | 0 | (.0) | 1 | (1.3) | 1 | (2.5) |
| Black or African American | 14 | (17.5) | 13 | (16.3) | 7 | (17.5) |
| Multiple | 6 | (7.5) | 7 | (8.8) | 4 | (10.0) |
| White | 58 | (72.5) | 57 | (71.3) | 28 | (70.0) |
| Ethnicity | ||||||
| Not Hispanic or Latino | 24 | (30.0) | 23 | (28.8) | 11 | (27.5) |
| Hispanic or Latino | 56 | (70.0) | 57 | (71.3) | 29 | (72.5) |
| Baseline Flavivirus Status | ||||||
| Baseline Flavivirus -naïve (BFN) | 36 | (45.0) | 39 | (48.8) | 17 | (42.5) |
| Baseline Flavivirus- experienced (BFE) | 44 | (55.0) | 41 | (51.2) | 23 | (57.5) |
†All participants met the inclusion criterion of age 18 to 50 years old at vaccination. Actual day of birth is not collected; therefore, the standard rule for imputing the age by birth month resulted in misclassification of the one participant displayed as 51 years of age.